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Abstract
Purpose To compare the organization of human and rat
ocular medial recti muscles (MR).
Methods The cryosections of human and rat MR were
processed for myofibrillar ATPase (mATPase), succinate
dehydrogenase and glycerol-3-phosphate dehydrogenase.
To reveal myosin heavy chain (MyHC) isoforms, specific
monoclonal antibodies against MyHC-1/β- slow, α-cardiac
(-α), -2a, -2x, -2b, -extraocular (eom), -embryonic (-emb)
and -neonatal (-neo) were applied. The MyHC gene
expression was studied by in situ hybridization in human
muscle.
Results The muscle fibers were arranged in two distinct
layers in both species. In the orbital layer most fibers were
highly oxidative and expressed fast MyHC isoforms,
whereas slow and oxidative fibers expressed MyHC-1
and -α, some of them also MyHC-2a, -2x, -eom, very
rarely -emb, and –neo. In the global layer, slow fibers with
very low oxidative and glycolytic activity and three types
of fast fibers, glycolytic, oxidative and oxidative-glycolytic,
could be distinguished. The slow medium-sized fibers with
mATPase activity stable at pH 4.4 expressed mostly
MyHC-1 and -α in rat, while in humans they co-
expressed MyHC-1 with -2b, -2x, -eom, and -neo. In both
species, the fast fibers showed variable mATPase activity
after preincubation at pH 9.4, and co-expressed various
combinations of MyHC-2b, -2x, -2a and -eom but not -emb
and -neo. MyHC-2b expressing fibers were larger and
glycolytic, while MyHC-2a expressing fibers were smaller
and highly oxidative in both species. To our knowledge, the
present study is the first that demonstrated the expression
of MyHC-2b in any of human skeletal muscles. Though
the expression of MyHC genes did not correlate with the
immunohistochemical profile of fibers in human MR, the
expression of MyHC-2b gene was undoubtedly confirmed.
Conclusions Rat MR represent a good model that can be
applied to study human MR in experiment or disease,
however certain differences are to be expected due to
specific oculomotor demands in humans.
Keywords Ocular medialrectusmuscle.Rat.Human.
Histochemistry.Immunohistochemistry.
Myosinheavychainisoforms.Insituhybridization
Introduction
The extraocular muscles (EOM) are unique in their
structure and function. The extraordinary functional
demands including globe rotation, imposed upon these
muscles made them the fastest and the most fatigue
resistant skeletal muscles [10]. Compared to other skeletal
muscles they are not respecting the traditional fiber type
classification schemes. EOM differ in their histochemical
profile, type of innervation and fiber type distribution [48,
51].The sequential development of EOM fiber types is
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may follow a different sequence in frontal and lateral-eyed
species [36]. In rodents, the composition of EOM is in
principle similar to that of other mammals, including
humans, however species differences were reported and
mostly concern muscle fiber type characteristics [16].
Several attempts at classification of fiber types in EOM
of different mammals, i.e. rodents, monkeys, cats, sheep,
rabbits and humans have been made by studying the
morphology, histochemical characteristics and /or ultra-
structure [1, 2, 7, 9, 19, 25, 27, 30, 31, 39, 48, 55].
However, the most pertinent classification system used at
present is still descriptive and incorporates different
classification schemes [48]. It distinguishes among six fiber
types in EOM according to (i) their location in the global
(GL) or orbital layer (OL), (ii) type of innervation (i.e.
singly (SIF) and multiply (MIF) innervated fibers) [35], (iii)
the staining for the myofibrillar adenosintriphosphatase
(mATPase) reaction after preincubation in acid and alkaline
medium (slow or type I and fast or type II fibers), and (iv)
metabolic profile (oxidative, oxidative-glycolytic, glycolyt-
ic). Still, this scheme remains limited in recognizing the full
extent of the muscle fiber heterogeneity in EOM, not
considering the myosin heavy chain (MyHC) isoform
composition, as suggested by McLoon and co-workers [28].
In fact, MyHC isoforms are the ones that determine the
activity of mATPase and the shortening velocity of
myofibers. In large human and rat skeletal muscles four
fiber types (I, IIc, IIa, IIb in rat and I, IIc, IIa, IIx in
humans) can be distinguished with the histochemical
reaction for mATPase after preincubation in alkaline and
acid media. Each fiber type expresses corresponding MyHC
isoform, except type IIc fibers, which co-express MyHC-1
and -2a [12, 35]. However, in rat, an additional fast MyHC,
i.e., IIx or IId (henceforth -2x) can be distinguished
immunohistochemically [4, 42].
In spite of all the complex research, the classification of
muscle fiber types in EOM is still not fully clarified, and
neither is the correlation between its structure and function.
The studies that considered the MyHC composition of the rat
or human EOM [4, 6, 8, 13, 19, 20, 23, 34, 40, 41, 51, 55,
56] applied different methods and therefore the results are
mostly not comparable. The reported expression of MyHC
isoforms in EOM is not consistent although it is generally
agreed that EOM express all the MyHC isoforms present in
other striated muscles. Besides these common MyHC
isoforms, the EOM-specific extraocular (MyHC-eom), α-
cardiac (MyHC-α) and developmental MyHC isoforms, i.e.,
MyHC-embryonic (-emb) and -neonatal (-neo) are expressed
in EOM as well.
The parallel data on serial histo- and immunohistochem-
ical EOM profiles of MyHC isoforms in rat and human
EOM have been scarce so far. In this study, we applied the
above-mentioned methods and in case of human EOM in
situ hybridization as well to obtain an additional insight
into the fiber type characteristics and MyHC isoform
expression in normal rat and human ocular medial rectus
muscles (MR). The purpose of this study was also to
determine whether the rat EOM could serve as a model for
human EOM structure in experiment and disease, despite
rat’s less complex visuomotor repertoire.
Methods
Materials
In this study, ten whole ocular medial rectus (MR) muscles
of 2 to 3-month old female Wistar rats with 220–250 g body
weight and ten human post-mortem MR muscles were
studied. The human EOM were obtained within 12 h after
sudden death of presumably healthy males (22 to 56 years of
age). The study was designed in compliance with Helsinki
ethical requirements and approved by the state ethical
committee. The rats were painlessly exsanguinated under
ether anesthesia. The whole muscle samples were immedi-
ately frozen in liquid nitrogen and cut into 10-μm-thick cross
sections.
Histochemistry
Both human and rat MR muscle sections were processed
for histochemical demonstration of the mATPase activity
after preincubation at pH 4.4 and 9.4 [14, 32], for succinate
dehydrogenase (SDH) [38] and glycerol-3-phosphate dehy-
drogenase activity (α-GPDH) [22].
Immunohistochemistry
MyHC isoforms in individual muscle fibers were demon-
strated by monoclonal antibodies directed against various
MyHC isoforms of rat: BA-D5 (MyHC-1 or β-slow), SC-
71 (MyHC-2a), BF-35 (MyHC-2x by exclusion), BF-F3
(MyHC-2b) [42]. Two commercially available antibodies
specific to developmental (MyHC-emb) and neonatal
(MyHC-neo) MyHC isoforms (Novocastra) were also used.
In some of the rat and human muscle samples, additional
antibodies were applied: MYH6 specific to MyHC-α
(Sigma Prestige Antibodies), 6H1, specific to MyHC-2x
of various species, 10F5, specific to MyHC-2b (applied
only in human samples), and 4A6, specific to MyHC-eom.
The last three antibodies were purchased by Developmental
Studies Hybridoma Bank at the University of Iowa [24, 47].
The appropriate dilutions of primary antibodies (in phos-
phate buffered saline with the addition of 0.3–0.5% normal
bovine serum) were established. The peroxidase-conjugated
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the secondary antibody. To reveal the binding of antibodies,
diaminobenzidine tetrahydrochloride (DAB, 0.05%) dis-
solved in 0.2 M acetate buffer, pH 5.2 with 0.01%
hydrogen peroxide) or 4-chloro-1-naphthol (C1N, 0.05%,
dissolved in 50 mM TRIS-HCl buffer, pH 7.4–7.6) were
used as chromogens. The control sections were incubated
without the primary antibody.
In situ hybridization
Serial cryosections of human ocular MR muscles were
processed for in situ hybridization with probes, specific to
mRNA transcripts of 1 or ß-slow, 2a, 2x, 2b, embryonic
and neonatal MyHC genes [44]. The riboprobes were
prepared with digoxigenin-labeled UTP according to the
guidelines of the manufacturer (Roche Molecular Biochem-
icals). In situ hybridization procedure was adapted from
Horton and co-workers [17] with minor modifications [47].
Fiber typing
For fiber typing, at least 2,000–2,500 fibers per muscle
were sampled. The data were collected independently and
separately for every section and layer, and each fiber type.
From each histochemically stained muscle section and each
section processed for MyHC isoform detection photos were
taken or images were captured by the video camera.
Identical fibers were marked on successive serial sections.
Further, their staining pattern with mATPase, SDH, α-
GPDH and the expression of different MyHC isoforms
were compared to determine the previously described six
main fiber types [51].
Results
Arrangement of muscle fibers into layers
In human and rat ocular MR muscles, the fibers were
arranged mainly into two layers: the peripheral orbital layer
(OL), and the internal global layer (GL). The layers were
more distinct in rat, in which the OL was narrow, it
consisted of smaller muscle fibers (mostly with diameter
less than 20 µm). The GL was wider and constituted the
predominating muscle portion with larger muscle fibers
(diameters mostly from 20 to 40 µm). In humans, however,
such a distinct separation into layers was not that obvious,
because of more gradual muscle fiber type transition from
the OL over larger intermediate zone to the GL. There was
also a more extensive layer of perimysium surrounding
human MR muscle bundles compared to rat MR muscle
bundles (Fig. 1a, b). Though larger human ocular MR
muscles, the diameters of human and rat muscle fibers did
not differ very much (human fiber diameter range 7.1–
40.3 µm vs. rat 10.6–38.4 µm in the GL and human 3.4–
26.6 µm vs. rat 5.5–23.4 µm in the OL) (Fig. 1a, b).
Muscle fiber types determined according to the mATPase
reaction and metabolic profile
Muscle fibers of very similar characteristics could be found
in both human and rat muscles. Serial profiles of EOM
fibers from the midbelly muscle region across different
histochemical reactions are shown in Fig. 2 and Table 1.
At least four fiber types in the GL and two in the OL
could be distinguished in both species according to the
reaction for mATPase and the fiber metabolic profile as
well. Two main categories, i.e., slow or type I fibers and
fast or type II fibers could be distinguished. Type I fibers
were lightly stained after alkaline preincubation and darkly
after the acid preincubation. The fibers with the opposite
staining characteristics were classified as fast or type II
fibers. Further sub-grouping of fast fibers was achieved
according to their metabolic profile revealed by the reaction
for SDH and α-GPDH into three subtypes: oxidative,
glycolytic, and oxidative-glycolytic.
In the GL of both species, the muscle fibers were
arranged in a rosette-like pattern, where each rosette was
composed of a central slow or type I fiber, surrounded by at
least all three, the above-mentioned subtypes of fast or type
II fibers (Fig. 2). The slow or type I fibers displayed rather
low oxidative and glycolytic activity (Fig. 2).
In the OL, where in both species oxidative fast fibers
predominated over less oxidative slow fibers (70–97% vs.
3–30%), the oxidative capacity of all fibers was generally
higher and the glycolytic one lower than those of fibers in
the GL (Figs. 1a, b and 2).
In the GL of the human MR midbelly only, the share of
slow or type I fibers was higher than that in the rat MR
muscles (10–30% vs. 10%). In general, the human MR
muscle fibers were also more oxidative than the rat muscle
fibers. An additional difference among the muscles of both
species pertains to the connective tissue separating the
muscle fascicles, which was in the human MR more
extensive than in the rat MR muscle (Figs. 1a, b, 2 and 3).
Expression of MyHC isoforms and transcripts
In both layers of both species, slow or type I fibers,
classified according to mATPase reaction, expressed
MyHC-1 as they were labeled by BA-D5 antibody. These
fibers were also labeled by BF-35 antibody, which
recognizes all MyHC isoforms, except -2x. Most of type I
fibers were unlabeled by SC-71, specific to MyHC-2a of rat
(Figs. 3 and 6). In human skeletal muscles, type I fibers
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rat. Two other antibodies, 6H1 and 10F5, specific to
MyHC-2x and -2b of various species, to our knowledge
for the first time applied in EOM in this study, also labeled
most of type I or BA-D5 positive fibers, 6H1 only weakly,
but 10F5 intensively (Fig. 4). But type I fibers of rat were
not labeled by these three antibodies (not shown). Most of
type I fibers of both species in both layers were recognized
by the antibody specific to MyHC-α, (Table 1, see also the
results of our previous study [51]).
In the GL and OL of human MR muscle the fast or
type II fibers were labeled by the antibodies specific to
rat MyHC-2a (SC-71), -2x (BF-35, stains all MyHC except
-2x, not shown, see our previous study [51]), and weakly
with the antibody BF-F3, against rat MyHC-2b (Fig. 3).
The other antibody specific to MyHC-2x, 6H1, also labeled
all human type II fibers (Fig. 4). Contrary to BF-F3, the
10F5 antibody, specific to MyHC-2b as well, stained only
some type II fibers (Fig. 4). Some of the type II fibers were
stained with the antibody 4A6, specific to MyHC-eom
(Fig. 5), and rarely with the antibodies directed against
MyHC-emb and -neo isoforms as well (not shown), the
latter being expressed only in few type II fibers.
In the rat GL, some type II fibers of smaller diameter
expressed MyHC-2a as they were stained by SC-71
antibody. Most of them obviously co-expressed variable
proportion of MyHC-2b and MyHC-eom, as they were
moderately labeled by BF-F3 and by 4A6 antibody as well
(Fig. 5). The type II fibers with larger diameter were either
unlabeled by BF-35 and stained by 6H1 (Fig. 6) or stained
to variable extent by 4A6 antibody (Fig. 5a), indicating that
they expressed either MyHC-2x or co-expressed MyHC-2x
and -eom. The rest of type II fibers, located mainly at the
outer border of a fascicle, were intensively stained by BF-
F3 antibody, thus assumed to express only MyHC-2b.
There was no expression of MyHC-emb and -neo isoforms
within muscle fibers in the GL (not shown).
In some fascicles of the OL of rat almost all type II and
type I fibers were stained by 4A6 antibody (MyHC-eom),
(Fig. 5). The antibody against MyHC-α labeled many type
II fibers as well. Similarly, there was uneven distribution of
fibers expressing MyHC-2a (SC-71 positive) and -2x (BF-
35 negative, 6H1 positive), for the latter two see Fig. 6.
Actually, there were fascicles with fibers expressing
MyHC-eom (Fig. 5), -2a, -2x and -2b, and fascicles with
fibers expressing MyHC-emb isoform (not shown). The
MyHC-neo isoform was either not expressed or present
only in scarce fibers of rat OL (Fig. 5).
As demonstrated by in situ hybridization technique, in
human type I fibers the corresponding 1 or β-slow MyHC
transcripts were predominantly expressed, but they seemed
to be expressed in some type II fibers as well. Similarly, 2a
MyHC transcripts were abundantly expressed in many type
II fibers, whereas 2x and 2b MyHC transcripts were
revealed only in a minor population of type II fibers. The
embryonic and neonatal MyHC transcripts were present
only in few fibers, the neonatal ones being much scarcer
than the former ones. Comparing the expression of MyHC
transcripts with immunohistochemical profile no clear
correlation could be found (Fig. 4).
Discussion
Inthisstudywehaveprovedthatalmostidenticalmusclefiber
types exist in rat and human extraocular muscles. The
majority of fibers are hybrid fibers, co-expressing two or
more MyHC isoforms. To our knowledge in this study the
expression of MyHC-2b isoform and MyHC gene transcripts
in human EOM muscle has been demonstrated for the first
time. Furthermore, to our knowledge this is the first study in
which the distribution of MyHC isoforms in the extraocular
muscle fibers of different species was compared.
We confirmed that muscle fibers of human and rat MR
muscle are organized into a thicker GL and a thinner OL
[33]. Previously described marginal zone (MZ) adjacent to
the OL was more evident in human than in rat ocular MR
muscles, however it was thin and was to our observation
Fig. 1 Cross section of a hu-
man and b rat ocular medial
rectus muscle. Histochemical
staining for succinate dehydro-
genase (SDH) exhibits higher
oxidative activity in the thinner
orbital layer than in the thicker
global layer. Human MR muscle
is much larger with a broad
intermediate layer and a lot of
connective tissue separating
muscle fascicles. Scale bar
50 µm
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GL [55].
As previously found in rat [48, 49], the muscle fibers of
larger diameter (from 20 to 40 μm) with various metabolic
activity were present in the GL, while in the OL smaller,
(less than 20 μm), mostly highly oxidative muscle fibers
were found in both species. The human MR muscles were
larger due to the higher absolute number of muscle fibers,
while the muscle fiber diameters were within the range of
rat muscle fiber diameters. Interestingly, the muscle fibers
Fig. 2 Histochemical staining of serial cross sections from the orbital
(OL) and global layer (GL) of human (left column) and rat (right
column) ocular medial rectus muscle, assayed for mATPase after
preincubation at pH 9.4 (fibers number 1 are fast fibers, stained dark),
(slow fibers are number 2, light fibers), mATPase after preincubation
at pH 4.4 (number 1 fibers are light, slow fibers are dark, number 2),
α GPDH and SDH. Four different fiber types are indicated in the
global muscle layer (slow numbered as 6, fast oxidative numbered as
3, fast oxidative- glycolytic as 4, fast glycolytic numbered as 5). Scale
bar 50 µm
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in human EOM (e.g., 8,000–11,800 fibers in monkey vs.
17,700 to 24,500 fibers in humans) [20, 21].
Inlargeskeletalmuscles,threetofourmajorfibertypescan
be revealed by mATPase histochemistry [12]. However, in
ocular MR muscles the mATPase histochemistry alone was
insufficient to completely distinguish fiber subtypes although
a variable incubation time in alkaline and acid media had
been used within a wide span of pH values [39, 50, 51].
Nevertheless, following the already described simplified
classification system applied so far for EOM fiber types ac-
c o r d i n gt ow h i c hs i xf i b e rt y p e sc an be distinguished regarding
to their location, type of innervation [36, 37, 48, 55], the
mATPase activity and metabolic profile [37]. Slow fibers
determined in this study obviously corresponded to multiply
innervated fibers (MIF), while fast fibers corresponded to
singly innervated fibers (SIF) described in other studies [37,
48]. In the GL we could identify at least three fast fiber types
(labeled as 3, 4, and 5), besides one slow or one hybrid slow/
fast fiber type (labeled as 6). Fiber type 3 was, oxidative and
thus obviously fatigue resistant, fiber type 5 was glycolytic
and must be fatigable, and fiber type 4 was of intermediate
oxidative-glycolytic type (Table 1 and Fig. 2). In the OL,
additionally, one fast oxidative fiber type (number 1, Table 1,
Fig. 2) in both, human and rat MR muscles was identified.
In both species the single slow type fibers in the GL
(number 6 in Table 1 and Fig. 2) and OL (number 2,
Table 1, Fig. 2) exhibited low oxidative and low glycolytic
activity. These were fatigable pure slow or hybrid fibers
coexpressing slow MyHC with other fast MyHC isoforms.
The functional role of these fibers is not well understood.
Since these global slow type fibers, (called also MIF
fibers), develop first they probably allow proprioceptive
information to be used in visual system development (36).
Orbital fast fibers (called also SIF fibers) mature the last
and may directly impact the range and precision of eye
movements. They contain the largest bunches of mitochon-
dria, which is consistent with the elevated fatigue resistance
and a sustained level of eye position maintenance.
To better define the fiber types according to their oxidative
capacity, the reaction for SDH was used in the present study, as
the activity of the other marker for oxidative metabolism, the
nicotineamide adenine dinucleotide dehydrogenase (NADH)
is generally very high in EOM and it hardly distinguishes
among fiber types, especially in human EOM [19, 50].
However, the reported proportions of GL slow fibers in
human EOM vary, ranging from 10 to 30% [55]. Such
variability in results is most probably due to the variable
length of muscle fibers, extending from the proximal to the
distal part of human extraocular muscle [2, 27, 39, 40, 48, 55].
The unique extraocular MyHC isoform (MyHC-eom),
considered as a fast one and not detected in limb muscles, is
obviously abundantly expressed in EOM [3, 56]. Until
recently, its presence could only be proved with SDS
polyacrylamide gel electrophoresis (SDS-PAGE). The share
of MyHC-eom confirmed in rat EOM homogenates was 25
% of the total muscle myosin [3, 51]. In this study, many OL
muscle fibers of both species stained positively with the
commercially available monoclonal antibody 4A6 against
MyHC-eom. On the contrary, the fibers of the GL were
labeled less intensively with this antibody (Fig. 5). Therefore
we assume that MyHC-eom is co-expressed with other
isoforms in many fibers, especially in the OL. Similarly,
Rubinstein and Hoh [40] found MyHC-eom in orbital fast
fibers in rat EOM as well Kjellgren and co-workers reported
that approximately 25% fibers in GL of other three human
Table 1 Histochemical and immunohistochemical characteristics of human and rat ocular medial rectus muscle fibers
Fiber type MyHC isoform mATPase (pH) SDH αGPDH
Human % Rat % 9.4 4.4 Human and rat
Orbital layer
1 SIF# a,x,b,eom,(emb,neo)* 70–97 a,x,b,eom,(emb,neo)* 70–97 + – +++ ±
2 MIF# I,a,x,b,eom,(emb,neo)* 30–3 I,a,x,eom,(emb,neo)* 30–3 − ++ + ±
Global layer
3 SIF# a,x,eom 30–25 a,x,eom 30 + − +++ −
4 SIF# a,x,b,eom 30–25 a,x,b,eom 35 + − +++ ++
5 SIF# b,x,eom 25–20 b,x,eom 25 + − ± +++
6 MIF# I (x,b,eom,neo)* 10–30 I,(eom)* 10 − +± ±
I = MyHC ß/slow, αcardiac, a = MyHC-2a, b = MyHC-2b, x = MyHC-2x, eom = MyHC-extraocular, emb = MyHC-embryonic, neo = MyHC-
neonatal
* isoforms in brackets are expressed in some fibers only
Enzyme activity: - (none), ± (very low), + (low), ++ (intermediate), +++ (high)
# For a better understanding of the existing literature on extraocular muscles, we also add the nomenclature used with classifying fibers according
to the type of innervation: SIF = singly innervated fibers, MIF = multiply innervated fibers
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expressed MyHC -eom and -2a, but contrary to our findings
they found very few MyHC-eom expressing fibers (3%) in
the OL [19]. Further, in the rabbit EOM the MyHC-eom
expression was determined in both, the GL and OL [5],
while in dog its presence was confirmed only in the OL [5].
The presence of another fast MyHC isoform, i.e., -2x,
expressed in large skeletal muscles as well, was not clearly
confirmed in EOM due to lack of an antibody specific to
MyHC-2x and due to similar migration of MyHC-2a and
-2x isoforms in gels after SDS-PAGE in previous studies [3,
19]. However, applying an antibody specific to MyHC-2x
(6H1), in this study we undoubtedly demonstrated that
MyHC-2x isoform is abundantly expressed in human EOM
fibers and in many rat muscle fibers of both layers.
Furthermore, applying monoclonal antibodies BF-F3 in
rat and 10F5 in humans we confirmed the presence of
MyHC-2b isoform, not only in rat but in human EOM as
well. To our knowledge this is the first study in which
MyHC-2b isoform has been revealed in any human skeletal
muscle, though 2b MyHC transcripts were demonstrated in
human external abdominal oblique and masseter muscles
[17]. It should be stressed that the 10F5 antibody did not
label any fiber in large limb muscles (biceps femoris, vastus
intermedius, vastus lateralis), but it did in human EOM,
indicating that MyHC-2b isoform is expressed in these
“specific, very fast contracting” muscles.
Furthermore, the expression of MyHC-2b isoform in
human MR was additionally confirmed with undoubtedly
revealed expression of MyHC-2b transcripts by in situ
Fig. 3 Immuno-peroxidase staining of serial cross sections from the
orbital (OL) and global muscle layer (GL) of human (left column) and
rat (right column) medial ocular rectus muscle, assayed for myosin
heavy chain isoforms: MyHC-1 (β slow) (BA-D5 as monoclonal
antibody), MyHC-2a (SC-71), MyHC-2b (BF-F3). Two fiber types are
indicated in the orbital muscle layer (numbered 1 and 2). Four
different fiber types are indicated in the global muscle layer
(numbered as 6, and 3, 4, 5). Scale bar 50 µm
Graefes Arch Clin Exp Ophthalmol (2009) 247:1505–1515 1511hybridization technique (Fig. 4). Though the expression of
MyHC gene transcripts in human EOM did not correlate
well with MyHC isoform expression, it was not completely
uninformative as the probe specific for MyHC-2b tran-
scripts hybridized in MR, but gave absolutely negative
results in the large limb muscles (not shown), placed on the
same slide as MR muscles and processed simultaneously
for in situ hybridization technique.
Fig. 4 MyHC transcript and
isoform expression, respective-
ly, revealed by in situ hybrid-
ization and
immunohistochemistry in hu-
man extraocular medial rectus
muscle. In the left column β-
slow (a), 2a (b), 2x (c) and 2b
(d) MyHC transcript expression
is presented. In the right column
MyHC isoforms are revealed by
specific monoclonal antibodies:
e. MyHC-1 (BA-D5), f. MyHC-
2a and -2x (SC-71), g. MyHC-
2x (6H1) and h. MyHC-2b
(10F5). Note that the MyHC
transcript and isoform expres-
sion do not correlate. Scale bar
100 µm
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isoform expression could be a possible posttranscriptional
MyHC gene regulation not only for MyHC-2b but also for
other isoforms [15]. Another possibility for so ambiguous
results of in situ hybridization technique could also be that
the expression of MyHC transcripts in EOM is less
abundant than in large skeletal muscles and that the method
is not sensitive enough to offer better results, though good
results were obtained in large skeletal muscles [47].
Similarly, as found in human EOM, MyHC-2b expres-
sion has been detected in bovine EOM but not in trunk and
limb muscles [26, 54]. According to previous studies [7, 40,
51, 52], MyHC-2b is the predominant isoform in the rat
EOM global region (50%). In dog, the predominance of
MyHC-2b isoform (50%) in the GL of the muscle belly was
also found, though like in humans it was not found in large
skeletal muscles [46]. In the OL of the belly region MyHC-
eom predominated (65–75% of total MyHC) [5]. Evaluat-
ing mRNA levels by competitive polymerase chain reaction
high expression of MyHC transcripts coding for fast MyHC
isoforms (MyHC-2x 29.9%, MHC-2a 29.3%, MyHC-2b
24.5%) was also found in the adult rat EOM [23].
Another specificity of EOM muscles is the expression of
developmental MyHC isoforms even in adult stage. The
presence of MyHC-emb and -neo isoforms predominantly
in OL within the midbelly region of adult EOM, reported
previously [34, 40, 51, 53, 55] and confirmed in this study,
seems to be a unique characteristic of the muscles
innervated by cranial nerves. However, it was found that
the pattern of MyHC isoform expression may change along
the length of rabbit and rat EOM fibers, whereby the
majority of fast and developmental MyHC isoforms
expressing fibers were present in the middle muscle region
of the OL and less in the GL [18, 25, 28, 41].
The characteristic co-expression of two to three MyHC
isoforms for EOM has been described in skeletal muscles as
well [43, 45, 47, 49, 51], however the co-expression in such
a great extent (over 60% of muscle fibers) is a unique
feature of EOM. Moreover, the hybrid fibers are even more
numerous in human than in rat MR muscles as found in this
study (Table 1, Figs. 3 and 5). However, the large share of
hybrid fibers in human EOM could also be ascribed to the
non-specificity of antibodies as they were not human
specific, while in rat their specificity has been proved
[42]. Nevertheless, the EOM fibers obviously exhibit
multiple patterns of gene regulation [56], and due to
continuous myogenesis triggered by the unique EOM stem
cells [29], the individual EOM fibers exhibited co-
Fig. 5 MyHC-eom expression
demonstrated by 4A6 antibody
in rat (a) and human (b) extra-
ocular medial rectus muscle.
Note that the presented rat mus-
cle section is serial to sections
presented in Fig. 6, whereas the
human one to those shown in
Fig. 4. Scale bar 100 µm
Fig. 6 MyHC-2x expression
demonstrated by BF-35 anti-
body (a), specific to all MyHC
isoforms except-2x and 6H1 (b),
specific to MyHC-2x in rat
extraocular medial rectus mus-
cle. Note the labeled (arrows)
MyHC-2x fibers, that are unla-
beled by BF35 (a) and moder-
ately stained by 6H1 (b). Scale
bar 100 µm
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layers of both species. The epigenetic influences, i.e., a
visual maldevelopment, metabolic and neuromuscular dis-
eases, probably essentially contribute to the understanding
how the EOM phenotype is established [8, 11, 19, 20, 28].
The comparison of EOM ontogeny in different species
confirms that the sequential development of fiber types is
conserved in frontal eyed animals but may follow a
different sequence in lateral-eyed species. Although differ-
ent cranial nerves innervate different extraocular muscles
the EOM are similar in their function and structure.
Actually, no difference in the fiber type composition of all
six EOM among cat, rabbit, guinea pig and rat was found
[2]. It is also assumed that the EOM fiber types are largely
conserved across mammalian species [37].
In conclusion, the neuromuscular junction formation
appears to follow similar pathways in rat, monkey, and
humans [36]. In the human and rat MR six muscle fibers
types can be distinguished that are arranged within two
muscle layers and are of similar size, in spite of large
difference in body size of the two species [50, 51]. However,
the muscle bundles in the human MR muscles are larger and
more numerous. Due to the more extensive connective tissue
that surrounds individual fibers and bundles in human MR
muscle, the fiber distribution does not appear as regular as in
rat MR muscles. What is the functional consequence of this
kind of the muscle arrangement, as well as greater extent of
MyHC isoform co-expression in human than in rat MR,
remains unclear and so does the overall understanding of the
complex MR muscle physiology and pathophysiology.
Nevertheless, similar structure of human and rat MR
muscle and similar characteristics of fiber types justify rat
MR muscles to be a suitable model for experimental studies
which would lead to better understanding of human MR
muscles in experiment or disease.
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